SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
EMISPHERE TECHNOLOGIES
(NQBB:EMIS Last Sale: .175 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQBB: (EMIS : $.175)
$11 million Market Cap at September 12, 2013
Employs 111.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
765 Old Saw Mill River Road Research Report Earnings Snapshot - Last 05/15/17
Tarrytown, NY 10591 Fact Sheet
Phone: (914) 347-2220 Financial Statements
Fax: (914) 347-2498 Peer Comparison
Annual Reports

Michael V. Novinski, CEO/Pres., Elliot M. Maza, CFO
Development stage products include Oral Unfractionated Heparin, a Phase III product, and Oral Low Molecular Weight Heparin, a Phase I product, for use in the cardiovascular therapeutic area; Oral Salmon Calcitonin, a Phase II product, and Oral Recombinant Parathyroid Hormone, a Phase I product, for the treatment of osteoporosis; Partner proprietary small molecule compounds, a Phase I product, which would be used in the treatment of bone-related diseases; and Oral Recombinant Human Growth Hormone, a Phase I product, for the treatment of growth disorders.
Historical Charts    Technical Analysis
No Historical Data available for EMIS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common EMIS $.175 $ 0 $.175 $.175 100 $.072 $.3753 60,687
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $10,620

A429
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex